Prosecution Insights
Prosecution Insights
7 pending office actions • 7 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (29%) |
| §103 only | 1 (14%) |
| Double-patenting + other | 1 (14%) |
| Multi-statute (no §101) | 3 (43%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| POLIAKOVA-GEORGAN, EKATERINA | 1 | 64.0% | +17.9% |
| DEKARSKE, MADELINE MCGUIRE | 1 | 0.0% | +0.0% |
| ARMATO JR, DENNIS IGNATIUS | 1 | 47.4% | +76.9% |
| NICKOL, GARY B | 1 | 45.3% | +28.7% |
| NIEBAUER, RONALD T | 1 | 41.1% | +33.7% |
| SULLIVAN, STEPHANIE LAUREN | 1 | 58.6% | +39.6% |
| MYERS, CARLA J | 1 | 49.0% | +46.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18278494 | ALLELE-SPECIFIC GENOME EDITING OF THE NR2E3 MUTATION G56R | POLIAKOVA-GEORGAN, EKATERINA | — |
| 18546300 | COMBINATION OF A SERCA2 INHIBITOR AND A STING ACTIVATOR FOR USE IN TREATING AND/OR PREVENTING CANCER | DEKARSKE, MADELINE MCGUIRE | — |
| 18250018 | C-TERMINAL SPARC FRAGMENTS FOR TREATING CANCER | NICKOL, GARY B | — |
| 18248240 | NOVEL PEPTOIDS AND USE THEREOF FOR PREVENTING OR TREATING CHRONIC PAIN | NIEBAUER, RONALD T | — |
| 17918468 | PROGNOSIS METHOD OF ACUTE MYELOID LEUKAEMIA | MYERS, CARLA J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18275331 | BILE SALTS BACTOSENSOR AND USE THEREOF FOR DIAGNOSITC AND THERAPEUTIC PURPOSES | ARMATO JR, DENNIS IGNATIUS | 30d overdue |
| 18278494 | ALLELE-SPECIFIC GENOME EDITING OF THE NR2E3 MUTATION G56R | POLIAKOVA-GEORGAN, EKATERINA | — |
| 18250018 | C-TERMINAL SPARC FRAGMENTS FOR TREATING CANCER | NICKOL, GARY B | — |
| 18248240 | NOVEL PEPTOIDS AND USE THEREOF FOR PREVENTING OR TREATING CHRONIC PAIN | NIEBAUER, RONALD T | — |
| 18002215 | BILE SALTS BACTOSENSOR AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES | SULLIVAN, STEPHANIE LAUREN | — |
| 17918468 | PROGNOSIS METHOD OF ACUTE MYELOID LEUKAEMIA | MYERS, CARLA J | — |
| Art Unit | Apps |
|---|---|
| 1637 | 1 |
| 1622 | 1 |
| 1651 | 1 |
| 1643 | 1 |
| 1658 | 1 |
| 1635 | 1 |
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18278494 | ALLELE-SPECIFIC GENOME EDITING OF THE NR2E3 MUTATION G56R | POLIAKOVA-GEORGAN, EKATERINA | 1637 | §101§103 | Final Rejection | — | Pending | Aug 23, 2023 |
| 18546300 | COMBINATION OF A SERCA2 INHIBITOR AND A STING ACTIVATOR FOR USE IN TREATING AND/OR PREVENTING CANCER | DEKARSKE, MADELINE MCGUIRE | 1622 | §102§103 | Non-Final OA | — | Pending | Aug 14, 2023 |
| 18275331 | BILE SALTS BACTOSENSOR AND USE THEREOF FOR DIAGNOSITC AND THERAPEUTIC PURPOSES | ARMATO JR, DENNIS IGNATIUS | 1651 | §103 | Final Rejection | 30d overdue | Pending | Aug 01, 2023 |
| 18250018 | C-TERMINAL SPARC FRAGMENTS FOR TREATING CANCER | NICKOL, GARY B | 1643 | §102§112 | Final Rejection | — | Pending | Apr 21, 2023 |
| 18248240 | NOVEL PEPTOIDS AND USE THEREOF FOR PREVENTING OR TREATING CHRONIC PAIN | NIEBAUER, RONALD T | 1658 | §103§112 | Final Rejection | — | Pending | Apr 06, 2023 |
| 18002215 | BILE SALTS BACTOSENSOR AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES | SULLIVAN, STEPHANIE LAUREN | 1635 | §103§112DP | Final Rejection | — | Pending | Dec 16, 2022 |
| 17918468 | PROGNOSIS METHOD OF ACUTE MYELOID LEUKAEMIA | MYERS, CARLA J | 1682 | §101§112 | Non-Final OA | — | Pending | Oct 12, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial